Immediate Impact
64 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
2024 Standout
Works of Benke Li being referenced
A phase I/II, open-label, multicenter study to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of HB0036 in patients with advanced solid tumors.
2024
Arbutin attenuates LPS-induced acute kidney injury by inhibiting inflammation and apoptosis via the PI3K/Akt/Nrf2 pathway
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Benke Li | 83 | 174 | 54 | 57 | 34 | 521 | |
| Yakun Li | 25 | 182 | 55 | 38 | 51 | 632 | |
| Nan Zhang | 170 | 159 | 35 | 61 | 24 | 579 | |
| Meifeng Liu | 17 | 203 | 80 | 6 | 40 | 528 | |
| Shamshad Alam | 63 | 172 | 49 | 16 | 37 | 597 | |
| Lirui Sun | 30 | 195 | 51 | 23 | 27 | 637 | |
| Linxiao Sun | 32 | 235 | 30 | 11 | 32 | 501 | |
| Živomir Petronijević | 33 | 179 | 164 | 99 | 25 | 532 | |
| Hao Cao | 8 | 409 | 33 | 14 | 35 | 589 | |
| Chong Yao | 28 | 273 | 130 | 12 | 35 | 581 | |
| Jinfu Lu | 17 | 180 | 147 | 38 | 29 | 601 |
All Works
Login with ORCID to disown or claim papers
Loading papers...